Revive Therapeutics Ltd. Annual cash flow by MarketWatch. View RVVTF net cash flow, operating cash flow, operating expenses and cash dividends.
The USPTO has granted Revive Therapeutics' (OTCQB:RVVTF) Patent No. 10,104,888, titled "Tannin-chitosan composites". This patent expands Revive’s coverage for the delivery of cannabinoids in various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results